A call for more dermatologic input into chronic graft-vs-host disease clinical trials.
Cowen
Edward W
EW
D001549:Benzamides; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003880:Dermatology; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012594:Scleroderma, Localized / Q000175:diagnosis / Q000188:drug therapy; D012871:Skin Diseases / Q000175:diagnosis* / Q000188:drug therapy
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate